z-logo
open-access-imgOpen Access
Bevacizumab based chemotherapy is a promising option in metastatic gallbladder adenocarcinoma
Author(s) -
Suhas Aagre,
Mubarakunnisa Tonse,
Avinash Talele,
Sanjeev Sharma,
Suresh H. Advani
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2315
Subject(s) - gemcitabine , bevacizumab , oxaliplatin , medicine , oncology , capecitabine , regimen , chemotherapy , cisplatin , cancer , surgery , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom